Clinical Trials · NCT01817569
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 2,948
- Start date
- Feb 2011
- Locations
- 46 sites, Japan
- Primary endpoint
- Adverse event incidence.